42 studies found for:    Open Studies | "Dwarfism"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
Condition: Short Stature
Intervention: Drug: Growth Hormone
2 Recruiting Short Stature Related Distress
Conditions: Idiopathic Short Stature;   Self Image
Interventions: Drug: GH treatment (Genotropin);   Drug: 1 year treatment with placebo followed by optional 3 years of GH treatment
3 Recruiting Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
Conditions: Dwarfism;   Osteogenesis Imperfecta
Intervention:
4 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature
Interventions: Drug: Niacin;   Drug: Placebo
5 Unknown  Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children
Conditions: Obesity;   Short Stature
Intervention:
6 Unknown  Constructing an Insulin-Like Growth Factor-based Prediction Model
Conditions: Growth Hormone Deficiency;   Idiopathic Short Stature;   Small for Gestational Age
Intervention:
7 Unknown  Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
Intervention:
8 Recruiting Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
Condition: Short Stature
Interventions: Drug: Letrozole;   Drug: Anastrozole
9 Recruiting Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
Conditions: Chronic Myelogenous Leukemia;   Short Stature
Intervention: Drug: Growth Hormone
10 Not yet recruiting Growth Hormone Secretion Following the Anaerobic Exercise
Condition: Short Stature
Intervention: Other: Anaerobic Test
11 Recruiting A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
Condition: Idiopathic Short Stature
Interventions: Drug: somatropin;   Drug: triptorelin
12 Unknown  Increlex Treatment of Children With Chronic Liver Disease and Short Stature
Conditions: Growth Failure;   Chronic Liver Disease
Intervention: Drug: Increlex
13 Recruiting Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Conditions: Genetic Disorder;   Noonan Syndrome
Intervention: Drug: somatropin
14 Recruiting Versartis Long-Term Extension Study of VRS-317
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: VRS-317
15 Recruiting Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
16 Unknown  Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism
Condition: Panhypopituitarism
Intervention: Drug: Transdermal Testosterone Gel
17 Recruiting Safety, PK/PD and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Condition: Growth Hormone Deficiency (GHD)
Interventions: Drug: ACP-001;   Drug: Human Growth Hormone
18 Not yet recruiting Bone Structure in Patients With Adult Onset Growth Hormone Deficiency Assessed Using High Resolution Peripheral Quantitative Computed Tomography
Condition: Adult Onset Growth Hormone Deficiency
Intervention:
19 Recruiting Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Condition: Adults Growth Hormone Deficiency.
Interventions: Drug: Pegvisomant;   Drug: Regular insulin
20 Recruiting A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: somatropin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years